Rxo (RXO) Current Assets (2021 - 2026)

Rxo (RXO) has reported Current Assets for 6 consecutive years, with $1.3 billion the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $1.3 billion, up 6.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 6.37% YoY), and the FY2025 annual result was $1.3 billion, down 1.64% from the prior year.
• Current Assets was $1.3 billion for Q1 2026 at Rxo, up from $1.3 billion in the prior quarter.
• Over five years, Current Assets peaked at $1.3 billion in Q4 2024 and troughed at $770.0 million in Q1 2024.
• Average Current Assets over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2025.
• The widest YoY moves for Current Assets: up 68.22% in 2024, down 25.17% in 2024.
• Over 5 years, Current Assets stood at $1.0 billion in 2022, then slipped by 22.64% to $796.0 million in 2023, then soared by 68.22% to $1.3 billion in 2024, then slipped by 1.64% to $1.3 billion in 2025, then increased by 1.37% to $1.3 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.